KLRC2 and COVID-19: Populations of adaptive NK cells with enhanced cytotoxic functions may also participate in antiviral defenses, as indicated by studies demonstrating increased circulation of NKG2C+ memory-like NK cells in patients with COVID-19 (Maucourant and others 2020).